Gene symbol | TPH2 |
---|---|
Aliases | - |
Protein Name | Tryptophan 5_hydroxylase 2 |
Function | This subpathway is part of the pathway serotonin biosynthesis, which is itself part of Aromatic compound metabolism. View all proteins of this organism that are known to be involved in the subpathway that synthesizes serotonin from L-tryptophan, the pathway serotonin biosynthesis and in Aromatic compound metabolism. |
Species | Human |
Editing Sites | 5 |
Disease | Psychiatric Disease; |
Description | RNA editing was shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. RNA editing is involved in the etiology of the psychiatric disease. |
RADR | RADAR |
REDIportal | REDI portal |
External links | Q8IWU9(Uniport); NM_173353 (NM id); 121278 (NCBI gene id); GeneCard; GTEx |
Sequence |
Enzyme | Editing type | Region | NT Seq Position | Molecular Consequence | Editing Level | Tissue | Editing Effect | Phenotype | Disease name | PMID |
---|---|---|---|---|---|---|---|---|---|---|
|
A-to-I | Exonic | 711 | Alternative splicing | Present | Brain | RNA editing is shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. | Affect disease processing | ||
|
C-to-U | Exonic | 830 | Alternative splicing | Present | Brain | RNA editing is shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. | Affect disease processing | ||
|
A-to-I | Exonic | 1297 | Alternative splicing | Present | Brain | RNA editing is shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. | Affect disease processing | ||
|
G-to-A | Exonic | 1322 | Alternative splicing | Present | Brain | RNA editing is shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. | Affect disease processing | ||
|
A-to-I | Exonic | 711 | Alternative splicing | Present | Brain | RNA editing is shown to inhibit the enzymatic activity of both TPH2 splice variants, the complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. | Affect disease processing |